Correlation Between Co Diagnostics and Cytosorbents Crp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Co Diagnostics and Cytosorbents Crp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Co Diagnostics and Cytosorbents Crp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Co Diagnostics and Cytosorbents Crp, you can compare the effects of market volatilities on Co Diagnostics and Cytosorbents Crp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Co Diagnostics with a short position of Cytosorbents Crp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Co Diagnostics and Cytosorbents Crp.

Diversification Opportunities for Co Diagnostics and Cytosorbents Crp

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between CODX and Cytosorbents is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and Cytosorbents Crp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytosorbents Crp and Co Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Co Diagnostics are associated (or correlated) with Cytosorbents Crp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytosorbents Crp has no effect on the direction of Co Diagnostics i.e., Co Diagnostics and Cytosorbents Crp go up and down completely randomly.

Pair Corralation between Co Diagnostics and Cytosorbents Crp

Given the investment horizon of 90 days Co Diagnostics is expected to under-perform the Cytosorbents Crp. But the stock apears to be less risky and, when comparing its historical volatility, Co Diagnostics is 3.16 times less risky than Cytosorbents Crp. The stock trades about -0.54 of its potential returns per unit of risk. The Cytosorbents Crp is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  101.00  in Cytosorbents Crp on September 1, 2024 and sell it today you would lose (4.00) from holding Cytosorbents Crp or give up 3.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Co Diagnostics  vs.  Cytosorbents Crp

 Performance 
       Timeline  
Co Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Cytosorbents Crp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cytosorbents Crp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Cytosorbents Crp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Co Diagnostics and Cytosorbents Crp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Co Diagnostics and Cytosorbents Crp

The main advantage of trading using opposite Co Diagnostics and Cytosorbents Crp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Co Diagnostics position performs unexpectedly, Cytosorbents Crp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will offset losses from the drop in Cytosorbents Crp's long position.
The idea behind Co Diagnostics and Cytosorbents Crp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.